Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2024
Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model
Chakradhar Yakkala, Jesus Corria-Osorio, Lana Kandalaft, et al.
Nature Communications
|
May 21, 2021
Interpretation of T cell states from single-cell transcriptomics data using reference atlases
Massimo Andreatta, Jesus Corria-Osorio, Sören Müller, et al.
Ebiomedicine
|
September 5, 2019
Modulation of CD4 T cell function via CD6-targeting
Raquel Filipa Freitas, Afonso Basto, Silvia C P Almeida, et al.
Nature Biotechnology
|
March 5, 2020
Author Correction: A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
Greta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
Nature Biotechnology
|
February 5, 2020
A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
Greta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
Nature Immunology
|
April 20, 2023
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8<sup>+</sup> T cells
Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, et al.
Immunity
|
September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma
Johanna Chiffelle, David Barras, Rémy Pétremand, et al.
Cancer Discovery
|
September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
Fernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.
Nature
|
April 24, 2024
PGE<sub>2</sub> inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function
Matteo Morotti, Alizee J Grimm, Helen Carrasco Hope, et al.
Science Immunology
|
February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanoma
David Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2024
Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model
Chakradhar Yakkala, Jesus Corria-Osorio, Lana Kandalaft, et al.
Nature Communications
|
May 21, 2021
Interpretation of T cell states from single-cell transcriptomics data using reference atlases
Massimo Andreatta, Jesus Corria-Osorio, Sören Müller, et al.
Ebiomedicine
|
September 5, 2019
Modulation of CD4 T cell function via CD6-targeting
Raquel Filipa Freitas, Afonso Basto, Silvia C P Almeida, et al.
Nature Biotechnology
|
March 5, 2020
Author Correction: A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
Greta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
Nature Biotechnology
|
February 5, 2020
A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
Greta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
Nature Immunology
|
April 20, 2023
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8<sup>+</sup> T cells
Jesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, et al.
Immunity
|
September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma
Johanna Chiffelle, David Barras, Rémy Pétremand, et al.
Cancer Discovery
|
September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
Fernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.
Nature
|
April 24, 2024
PGE<sub>2</sub> inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function
Matteo Morotti, Alizee J Grimm, Helen Carrasco Hope, et al.
Science Immunology
|
February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanoma
David Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Page
of 1